These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17057942)

  • 1. Sudden death risk stratification in hypertrophic cardiomyopathy: genetic and clinical bases.
    Piva e Mattos B
    Arq Bras Cardiol; 2006 Sep; 87(3):391-9. PubMed ID: 17057942
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy: management issues in the new millennium.
    Thaman R; Firoozi S; Hamid MS; McKenna WJ
    Curr Cardiol Rep; 2002 May; 4(3):226-32. PubMed ID: 11960592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk stratification of sudden death in hypertrophic cardiomyopathy in 2016].
    Dubourg O; Charron P; Sirol M; Siam-Tsieu V; Mansencal N
    Presse Med; 2016 Oct; 45(10):903-910. PubMed ID: 27234906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The never ending story of risk stratification for sudden death in hypertrophic cardiomyopathy.
    Christiaans I; Wilde AA
    Am J Cardiol; 2011 Jun; 107(12):1871. PubMed ID: 21640227
    [No Abstract]   [Full Text] [Related]  

  • 6. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
    Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ
    Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death in hypertrophic cardiomyopathy: risk stratification and prevention.
    Valgaeren G; Conraads V; Colpaert C; Rademakers F; Vrints C
    Acta Cardiol; 1998; 53(1):23-9. PubMed ID: 9638966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification in hypertrophic cardiomyopathy: fact or fiction?
    Hess OM
    J Am Coll Cardiol; 2003 Sep; 42(5):880-1. PubMed ID: 12957436
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic screening and risk assessment in hypertrophic cardiomyopathy.
    MacRae CA; Ellinor PT
    J Am Coll Cardiol; 2004 Dec; 44(12):2326-8. PubMed ID: 15607393
    [No Abstract]   [Full Text] [Related]  

  • 10. A Perspective on Personalized Therapies in Hypertrophic Cardiomyopathy.
    Goldspink PH; Warren CM; Kitajewski J; Wolska BM; Solaro RJ
    J Cardiovasc Pharmacol; 2021 Mar; 77(3):317-322. PubMed ID: 33298734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 12. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Cecchi F; McKenna WJ
    Br Heart J; 1994 Dec; 72(6 Suppl):S13-8. PubMed ID: 7873317
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.
    McKenna WJ; Behr ER
    Heart; 2002 Feb; 87(2):169-76. PubMed ID: 11796562
    [No Abstract]   [Full Text] [Related]  

  • 15. My approach to clinical management of hypertrophic cardiomyopathy.
    Maron MS
    Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetics of hypertrophic cardiomyopathy: what is the next step?
    Kuusisto J
    Heart; 2020 Sep; 106(17):1291-1292. PubMed ID: 32546508
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypertrophic cardiomyopathy and sudden cardiac death--ICD indications in the margin of uncertainty].
    Fauchère I; Duru F
    Praxis (Bern 1994); 2009 Aug; 98(17):941-52. PubMed ID: 19711287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy.
    Maron MS
    Can J Cardiol; 2015 Nov; 31(11):1402-6. PubMed ID: 26239004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sudden death (V). Identification and treatment of patients with hypertrophic cardiomyopathy at risk of sudden death].
    McKenna WJ; Monserrat Iglesias L
    Rev Esp Cardiol; 2000 Jan; 53(1):123-30. PubMed ID: 10701329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Jahnlová D; Tomašov P; Zemánek D; Veselka J
    Int J Cardiol; 2015; 186():3-4. PubMed ID: 25804453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.